OR WAIT null SECS
Fiber is cleared for use with Holmium laser in BPH
Irvine, CA-Trimedyne, Inc., has received FDA clearance to market its new VaporMAX fiber for use with its Holmium lasers in treating BPH and for use with compatible Holmium lasers made by other firms. According to the manufacturer, VaporMAX Side-Firing Laser Fibers vaporize an average of 3 grams of soft tissue per minute over 60 minutes of use, reducing physician and operating room time. The company reports that tests indicate that the product's durability is such that a single device should be sufficient to treat even large prostates. The new fiber qualifies for reimbursement under the higher-paying APC code 3525.
For more information, visit http://www.trimedyne.com/
Bifocal safety glasses adjust for perfect fit
For more information, visit http://www.visionusa.biz/
Natural agent offers relief for chronic pelvic pain, OAB
Compton, CA-Q-Urol has demonstrated effectiveness in relieving the symptoms of chronic pelvic pain syndrome and overactive bladder, according to its manufacturer, Farr Laboratories. Available in 900-mg, time-release tablets, the natural therapy is an extra-strength version (68% greater potency) of Prosta-Q, which contains the bioflavinoid quercetin and other compounds with antioxidant effects.
For more information, visit http://www.farrlabs.com/
Generic testosterone gel receives FDA approval
Corona, CA-Watson Pharmaceuticals, Inc., has received FDA approval of its abbreviated new drug application for its generic testosterone gel, 1% CIII. The preparation is indicated for replacement therapy in men with conditions associated with a deficiency or absence of endogenous testosterone.
For more information, visit http://www.watsonpharm.com/
Latex-free lap transducer cover improves comfort
For more information, visit http://www.civco.com/
Brochure helps patients better prepare for surgery
Rockville, MD-The Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ) offers a free brochure that can help patients make informed decisions about surgery. Available in English and Spanish, the brochure lists questions to ask about the nature of the surgery, costs, anesthesia, second opinions, alternative nonsurgical therapies and watchful waiting, consequences of not having surgery, risks and benefits of surgery, and time to recovery.
For more information, visit http://www.ahrq.gov/